Indomethacin

Generic name: Pronounced as (in doe meth' a sin)
Brand names
  • Indocin®
  • Tivorbex®
Click on drug name to hear pronunciation

Medical Content Reviewed By HelloPharmacist Staff

Last Revised - 08/15/2021

People who take nonsteroidal anti-inflammatory drugs (NSAIDs) (other than aspirin) such as indomethacin may have a higher risk of having a heart attack or a stroke than people who do not take these medications. These events may happen without warning and may cause death. This risk may be higher for people who take NSAIDs for a long time. Do not take an NSAID such as indomethacin if you have recently had a heart attack, unless directed to do so by your doctor. Tell your doctor if you or anyone in your family has or has ever had heart disease, a heart attack, or a stroke, if you smoke, and if you have or have ever had high cholesterol, high blood pressure, or diabetes. Get emergency medical help right away if you experience any of the following symptoms: chest pain, shortness of breath, weakness in one part or side of the body, or slurred speech.

If you will be undergoing a coronary artery bypass graft (CABG; a type of heart surgery), you should not take indomethacin right before or right after the surgery.

NSAIDs such as indomethacin may cause ulcers, bleeding, or holes in the stomach or intestine. These problems may develop at any time during treatment, may happen without warning symptoms, and may cause death. The risk may be higher for people who take NSAIDs for a long time, are older in age, have poor health, or drink large amounts of alcohol while taking indomethacin. Tell your doctor if you take any of the following medications: anticoagulants ('blood thinners') such as warfarin (Coumadin, Jantoven); aspirin; other NSAIDs such as diflunisal (Dolobid), ibuprofen (Advil, Motrin) and naproxen (Aleve, Naprosyn); oral steroids such as dexamethasone, methylprednisolone (Medrol), and prednisone (Rayos); selective serotonin reuptake inhibitors (SSRIs) such as citalopram (Celexa), fluoxetine (Prozac, Sarafem, Selfemra, in Symbyax), fluvoxamine (Luvox), paroxetine (Brisdelle, Paxil, Pexeva), and sertraline (Zoloft); or serotonin norepinephrine reuptake inhibitors (SNRIs) such as desvenlafaxine (Khedezla, Pristiq), duloxetine (Cymbalta), and venlafaxine (Effexor XR). Also tell your doctor if you have or have ever had ulcers or bleeding in your stomach or intestines, or other bleeding disorders. If you experience any of the following symptoms, stop taking indomethacin and call your doctor: stomach pain, heartburn, vomit that is bloody or looks like coffee grounds, blood in the stool, or black and tarry stools.

Keep all appointments with your doctor and the laboratory. Your doctor will monitor your symptoms carefully and will probably order certain tests to check your body's response to indomethacin. Be sure to tell your doctor how you are feeling so that your doctor can prescribe the right amount of medication to treat your condition with the lowest risk of serious side effects.

Your doctor or pharmacist will give you the manufacturer's patient information sheet (Medication Guide) when you begin treatment with indomethacin and each time you refill your prescription. Read the information carefully and ask your doctor or pharmacist if you have any questions. You can also visit the Food and Drug Administration (FDA) website (http://www.fda.gov/Drugs) or the manufacturer's website to obtain the Medication Guide.

Indomethacin is used to relieve moderate to severe pain, tenderness, swelling, and stiffness caused by osteoarthritis (arthritis caused by a breakdown of the lining of the joints), rheumatoid arthritis (arthritis caused by swelling of the lining of the joints), and ankylosing spondylitis (arthritis that mainly affects the spine). Indomethacin is also used to treat pain in the shoulder caused by bursitis (inflammation of a fluid-filled sac in the shoulder joint) and tendinitis (inflammation of the tissue that connects muscle to bone). Indomethacin immediate-release capsules and suspension (liquid) are also used to treat acute gouty arthritis (attacks of severe joint pain and swelling caused by a build-up of certain substances in the joints). Indomethacin is in a class of medications called NSAIDs. It works by stopping the body's production of a substance that causes pain, fever, and inflammation.

Indomethacin comes as a capsule, an extended-release (long-acting) capsule, and a suspension to take by mouth. Indomethacin capsules and liquid usually are taken two to four times a day. Extended-release capsules are usually taken one or two times a day. Indomethacin capsules, extended-release capsules, and suspension should be taken with food, immediately after meals, or with antacids. Take indomethacin at around the same times every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take indomethacin exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.

Swallow the extended-release capsules whole; do not split, chew, or crush them.

Shake the suspension well before each use to mix the medication evenly.

Your doctor may change the dose of your medication during your treatment. In some cases, your doctor may start you on a low dose of indomethacin and gradually increase your dose, not more often than once a week. In other cases, your doctor may start you on an average dose of indomethacin and decrease your dose once your symptoms are controlled. Follow these directions carefully and ask your doctor or pharmacist if you have any questions.

Indomethacin is also sometimes used to relieve fever, pain, and inflammation caused by many types of conditions or injuries, to reduce the amount of calcium in the blood, and to treat a certain type of low blood pressure. Talk to your doctor about the risks of using this medication for your condition.

This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.

Before taking indomethacin,

  • tell your doctor and pharmacist if you are allergic to indomethacin, aspirin or other NSAIDs such as ibuprofen (Advil, Motrin) and naproxen (Aleve, Naprosyn), any other medications, or any of the inactive ingredients in indomethacin capsules, suspension, or extended-release capsules. Ask your pharmacist for a list of the inactive ingredients.

  • tell your doctor and pharmacist what prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention the medications listed in the IMPORTANT WARNING section and any of the following: angiotensin-converting enzyme (ACE) inhibitors such as benazepril (Lotensin, in Lotrel), captopril, enalapril (Vasotec, in Vaseretic), fosinopril, lisinopril (in Zestoretic), moexipril (Univasc, in Uniretic), perindopril (Aceon, in Prestalia), quinapril (Accupril, in Accuretic, in Quinaretic), ramipril (Altace), and trandolapril (Mavik, in Tarka); angiotensin receptor blockers such as candesartan (Atacand, in Atacand HCT), eprosartan (Teveten), irbesartan (Avapro, in Avalide), losartan (Cozaar. in Hyzaar), olmesartan (Benicar, in Azor, in Benicar HCT, in Tribenzor), telmisartan (Micardis, in Micardis HCT, in Twynsta), and valsartan (in Diovan HCT, in Exforge); beta blockers such as atenolol (Tenormin, in Tenoretic), labetalol (Trandate), metoprolol (Lopressor, Toprol XL, in Dutoprol), nadolol (Corgard, in Corzide), and propranolol (Hemangeol, Inderal, Innopran); cyclosporine (Gengraf, Neoral, Sandimmune); digoxin (Lanoxin); diuretics ('water pills') such as triamterene (Dyrenium, in Dyazide); lithium (Lithobid); methotrexate (Otrexup, Rasuvo, Trexall); phenytoin (Dilantin, Phenytek); and probenecid (Probalan, in Col-Probenecid). Your doctor may need to change the doses of your medications or monitor you carefully for side effects.

  • tell your doctor if you have or have ever had asthma, especially if you also have frequent stuffed or runny nose or nasal polyps (swelling of the lining of the nose); heart failure; seizures; Parkinson's disease; depression or mental illness; or liver or kidney disease.

  • tell your doctor if you are pregnant, plan to become pregnant; or are breast-feeding. Indomethacin may harm the fetus and cause problems with delivery if it is taken around 20 weeks or later during pregnancy. Do not take indomethacin around or after 20 weeks of pregnancy, unless you are told to do so by your doctor. If you become pregnant while taking indomethacin, call your doctor.

  • you should know that indomethacin may cause fertility problems in women. Talk to your healthcare provider if you have concerns about fertility.

  • talk to your doctor about the risks and benefits of taking indomethacin if you are 65 years of age or older. Older adults usually should not take indomethacin because it is not as safe as other medications that can be used to treat the same condition.

  • if you are having surgery, including dental surgery, tell the doctor or dentist that you are taking indomethacin.

  • you should know that this medication may make you drowsy. Do not drive a car or operate machinery until you know how this medication affects you.

  • talk to your doctor about the safe use of alcohol during your treatment with indomethacin. Alcohol can make the side effects of indomethacin worse.

Unless your doctor tells you otherwise, continue your normal diet.

Take the missed dose as soon as you remember it. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.

  • Indomethacin may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

    • headache

    • dizziness

    • vomiting

    • diarrhea

    • constipation

    • ringing in the ears

  • Some side effects can be serious. If you experience any of the following symptoms or those mentioned in the IMPORTANT WARNING section, call your doctor immediately or get emergency medical treatment.

    • unexplained weight gain

    • shortness of breath or difficulty breathing

    • swelling in the abdomen, ankles, feet, or legs

    • fever, rash, lymph node swelling, or facial swelling

    • fever

    • blisters

    • rash

    • itching

    • hives

    • swelling of the eyes, face, tongue, lips, throat, or hands

    • difficulty breathing or swallowing

    • hoarseness

    • pale skin

    • fast heartbeat

    • excessive tiredness

    • unusual bleeding or bruising

    • lack of energy

    • nausea

    • loss of appetite

    • pain in the upper right part of the stomach

    • flu-like symptoms

    • yellowing of the skin or eyes

    • cloudy, discolored, or bloody urine

    • back pain

    • difficult or painful urination

    • blurred vision or other problems with sight

  • Indomethacin may cause other side effects. Call your doctor if you have any unusual problems while taking this medication.

  • If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).

Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture (not in the bathroom).

It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. http://www.upandaway.org

Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA's Safe Disposal of Medicines website (http://goo.gl/c4Rm4p) for more information if you do not have access to a take-back program.

In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.

Symptoms of overdose may include the following:

  • nausea

  • vomiting

  • headache

  • dizziness

  • confusion

  • extreme tiredness

  • feeling of numbness, pricking, burning, or creeping on the skin

  • seizures

Before having any laboratory test, tell your doctor and the laboratory personnel that you are taking indomethacin.

Do not let anyone else take your medication. Ask your pharmacist any questions you have about refilling your prescription.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

Drug Interaction
Moxifloxacin Moxifloxacin Indomethacin may increase the neuroexcitatory activities of Moxifloxacin.
Repaglinide Repaglinide Indomethacin may decrease the excretion rate of Repaglinide which could result in a higher serum level.
Montelukast Montelukast The metabolism of Montelukast can be decreased when combined with Indomethacin.
Insulin Glargine (rDNA origin) Injection Insulin Glargine (rDNA origin) Injection The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Indomethacin.
Leflunomide Leflunomide The risk or severity of adverse effects can be increased when Indomethacin is combined with Leflunomide.
Delavirdine Delavirdine The metabolism of Indomethacin can be decreased when combined with Delavirdine.
Nevirapine Nevirapine The metabolism of Indomethacin can be decreased when combined with Nevirapine.
Atorvastatin Atorvastatin Indomethacin may decrease the excretion rate of Atorvastatin which could result in a higher serum level.
Alendronate Alendronate The risk or severity of adverse effects can be increased when Indomethacin is combined with Alendronic acid.
Anagrelide Anagrelide The risk or severity of bleeding can be increased when Anagrelide is combined with Indomethacin.
Candesartan Candesartan The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Candesartan is combined with Indomethacin.
Cilostazol Cilostazol The serum concentration of Cilostazol can be increased when it is combined with Indomethacin.
Clopidogrel Clopidogrel The risk or severity of bleeding can be increased when Indomethacin is combined with Clopidogrel.
Erythromycin and Sulfisoxazole Erythromycin and Sulfisoxazole Indomethacin may decrease the excretion rate of Erythromycin which could result in a higher serum level.
Estrogen and Progestin (Oral Contraceptives) Estrogen and Progestin (Oral Contraceptives) The excretion of Conjugated estrogens can be decreased when combined with Indomethacin.
Fenofibrate Fenofibrate The metabolism of Indomethacin can be decreased when combined with Fenofibrate.
Guanfacine Guanfacine The therapeutic efficacy of Guanfacine can be decreased when used in combination with Indomethacin.
Magnesium Hydroxide Magnesium Hydroxide Indomethacin may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level.
Methylergonovine Methylergonovine The risk or severity of hypertension can be increased when Indomethacin is combined with Methylergometrine.
Miglitol Miglitol The risk or severity of hypoglycemia can be increased when Indomethacin is combined with Miglitol.
Mycophenolate Mycophenolate The metabolism of Mycophenolic acid can be decreased when combined with Indomethacin.
Naratriptan Naratriptan The risk or severity of hypertension can be increased when Indomethacin is combined with Naratriptan.
Olsalazine Olsalazine The therapeutic efficacy of Olsalazine can be decreased when used in combination with Indomethacin.
Paregoric Paregoric The metabolism of Morphine can be decreased when combined with Indomethacin.
Penbutolol Penbutolol Indomethacin may decrease the antihypertensive activities of Acebutolol.
Potassium Potassium Indomethacin may decrease the excretion rate of Potassium cation which could result in a higher serum level.
Prednisone Prednisone The risk or severity of gastrointestinal irritation can be increased when Indomethacin is combined with Prednisone.
Ranitidine Ranitidine The excretion of Ranitidine can be decreased when combined with Indomethacin.
Reserpine Reserpine Reserpine may decrease the excretion rate of Indomethacin which could result in a higher serum level.
Rizatriptan Rizatriptan Indomethacin may decrease the excretion rate of Rizatriptan which could result in a higher serum level.
Sumatriptan Sumatriptan Indomethacin may decrease the excretion rate of Sumatriptan which could result in a higher serum level.
Tacrolimus Tacrolimus The risk or severity of renal failure can be increased when Indomethacin is combined with Tacrolimus.
Tiludronate Tiludronate The risk or severity of gastrointestinal bleeding can be increased when Indomethacin is combined with Etidronic acid.
Triamcinolone Triamcinolone The risk or severity of gastrointestinal irritation can be increased when Indomethacin is combined with Triamcinolone.
Zolmitriptan Zolmitriptan The risk or severity of hypertension can be increased when Zolmitriptan is combined with Indomethacin.
Ampicillin Injection Ampicillin Injection Indomethacin may decrease the excretion rate of Ampicillin which could result in a higher serum level.
Doxycycline Injection Doxycycline Injection Indomethacin may decrease the excretion rate of Doxycycline which could result in a higher serum level.
Famotidine Injection Famotidine Injection The excretion of Famotidine can be decreased when combined with Indomethacin.
Fluconazole Injection Fluconazole Injection The metabolism of Indomethacin can be decreased when combined with Fluconazole.
Foscarnet Injection Foscarnet Injection The risk or severity of nephrotoxicity can be increased when Indomethacin is combined with Foscarnet.
Hydromorphone Injection Hydromorphone Injection Indomethacin may decrease the excretion rate of Hydromorphone which could result in a higher serum level.
Interferon Beta-1b Injection Interferon Beta-1b Injection The risk or severity of adverse effects can be increased when Interferon beta-1b is combined with Indomethacin.
Interferon Gamma-1b Injection Interferon Gamma-1b Injection The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Indomethacin.
Levofloxacin Injection Levofloxacin Injection Indomethacin may decrease the excretion rate of Levofloxacin which could result in a higher serum level.
Meperidine Injection Meperidine Injection Indomethacin may decrease the excretion rate of Meperidine which could result in a higher serum level.
Methylprednisolone Injection Methylprednisolone Injection The risk or severity of gastrointestinal irritation can be increased when Indomethacin is combined with Methylprednisolone.
Metoclopramide Injection Metoclopramide Injection Indomethacin may decrease the excretion rate of Metoclopramide which could result in a higher serum level.
Metronidazole Injection Metronidazole Injection The metabolism of Indomethacin can be decreased when combined with Metronidazole.
Morphine Injection Morphine Injection The metabolism of Morphine can be decreased when combined with Indomethacin.
Pamidronate Injection Pamidronate Injection The risk or severity of gastrointestinal bleeding can be increased when Indomethacin is combined with Pamidronic acid.
Vancomycin Injection Vancomycin Injection Indomethacin may decrease the excretion rate of Vancomycin which could result in a higher serum level.
Zidovudine Injection Zidovudine Injection The risk or severity of bleeding can be increased when Zidovudine is combined with Indomethacin.
Altretamine Altretamine Indomethacin may decrease the excretion rate of Amphetamine which could result in a higher serum level.
Cefuroxime Cefuroxime The risk or severity of nephrotoxicity can be increased when Indomethacin is combined with Cefuroxime.
Cyclosporine Cyclosporine Indomethacin may increase the immunosuppressive activities of Cyclosporine.
Ondansetron Ondansetron The metabolism of Ondansetron can be decreased when combined with Indomethacin.
Enoxaparin Injection Enoxaparin Injection The risk or severity of bleeding and hemorrhage can be increased when Indomethacin is combined with Enoxaparin.
Torsemide Torsemide The therapeutic efficacy of Torasemide can be decreased when used in combination with Indomethacin.
Olanzapine Olanzapine The metabolism of Indomethacin can be decreased when combined with Olanzapine.
Alosetron Alosetron The metabolism of Alosetron can be decreased when combined with Indomethacin.
Eprosartan Eprosartan The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Eprosartan is combined with Indomethacin.
Hydroxychloroquine Hydroxychloroquine The risk or severity of adverse effects can be increased when Indomethacin is combined with Hydroxychloroquine.
Meloxicam Meloxicam The risk or severity of adverse effects can be increased when Indomethacin is combined with Meloxicam.
Pantoprazole Pantoprazole The excretion of Indomethacin can be decreased when combined with Pantoprazole.
Risedronate Risedronate The risk or severity of gastrointestinal bleeding can be increased when Indomethacin is combined with Risedronic acid.
Sevelamer Sevelamer Sevelamer can cause a decrease in the absorption of Indomethacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Telmisartan Telmisartan The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Telmisartan is combined with Indomethacin.
Temozolomide Temozolomide The risk or severity of adverse effects can be increased when Indomethacin is combined with Temozolomide.
Zaleplon Zaleplon Indomethacin may decrease the excretion rate of Zaleplon which could result in a higher serum level.
Anakinra Anakinra The metabolism of Indomethacin can be increased when combined with Anakinra.
Linezolid Linezolid The risk or severity of adverse effects can be increased when Indomethacin is combined with Linezolid.
Pentosan Polysulfate Pentosan Polysulfate The risk or severity of bleeding and hemorrhage can be increased when Indomethacin is combined with Pentosan polysulfate.
Trimipramine Trimipramine The metabolism of Trimipramine can be decreased when combined with Indomethacin.
Etanercept Injection Etanercept Injection The metabolism of Indomethacin can be increased when combined with Etanercept.
Modafinil Modafinil The metabolism of Indomethacin can be decreased when combined with Modafinil.
Perindopril Perindopril The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Indomethacin is combined with Perindopril.
Tenofovir Tenofovir Indomethacin may increase the nephrotoxic activities of Tenofovir.
Choline Magnesium Trisalicylate Choline Magnesium Trisalicylate The risk or severity of adverse effects can be increased when Indomethacin is combined with Choline magnesium trisalicylate.
Sirolimus Sirolimus The risk or severity of adverse effects can be increased when Indomethacin is combined with Sirolimus.
Dutasteride Dutasteride The risk or severity of hypertension can be increased when Indomethacin is combined with Dutasteride.
Epinephrine Injection Epinephrine Injection The metabolism of Indomethacin can be decreased when combined with Epinephrine.
Epirubicin Epirubicin The risk or severity of adverse effects can be increased when Indomethacin is combined with Epirubicin.
Eplerenone Eplerenone The therapeutic efficacy of Eplerenone can be decreased when used in combination with Indomethacin.
Escitalopram Escitalopram The risk or severity of gastrointestinal bleeding can be increased when Indomethacin is combined with Escitalopram.
Olmesartan Olmesartan The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Olmesartan is combined with Indomethacin.
Zonisamide Zonisamide The metabolism of Zonisamide can be decreased when combined with Indomethacin.
Adalimumab Injection Adalimumab Injection The metabolism of Indomethacin can be increased when combined with Adalimumab.
Aripiprazole Aripiprazole The risk or severity of hypertension can be increased when Indomethacin is combined with Aripiprazole.
Atomoxetine Atomoxetine Indomethacin may decrease the excretion rate of Atomoxetine which could result in a higher serum level.
Dexmethylphenidate Dexmethylphenidate The risk or severity of hypertension can be increased when Indomethacin is combined with Dexmethylphenidate.
Ezetimibe Ezetimibe The metabolism of Ezetimibe can be decreased when combined with Indomethacin.
Glatiramer Injection Glatiramer Injection The risk or severity of adverse effects can be increased when Indomethacin is combined with Glatiramer.
Atazanavir Atazanavir The metabolism of Indomethacin can be decreased when combined with Atazanavir.
Almotriptan Almotriptan Indomethacin may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Eletriptan Eletriptan The metabolism of Indomethacin can be decreased when combined with Eletriptan.
Rosuvastatin Rosuvastatin The excretion of Rosuvastatin can be decreased when combined with Indomethacin.
Aprepitant Aprepitant The metabolism of Indomethacin can be decreased when combined with Aprepitant.
Emtricitabine Emtricitabine Indomethacin may decrease the excretion rate of Emtricitabine which could result in a higher serum level.
Memantine Memantine Indomethacin may decrease the excretion rate of Memantine which could result in a higher serum level.
Tadalafil Tadalafil Indomethacin may decrease the excretion rate of Tadalafil which could result in a higher serum level.
Frovatriptan Frovatriptan The risk or severity of hypertension can be increased when Indomethacin is combined with Frovatriptan.
Gemifloxacin Gemifloxacin Indomethacin may increase the neuroexcitatory activities of Gemifloxacin.
Progesterone Progesterone Progesterone may decrease the excretion rate of Indomethacin which could result in a higher serum level.
Infliximab Injection Infliximab Injection The metabolism of Indomethacin can be increased when combined with Infliximab.
Oxandrolone Oxandrolone The metabolism of Indomethacin can be decreased when combined with Oxandrolone.
Protriptyline Protriptyline The risk or severity of hypertension can be increased when Indomethacin is combined with Protriptyline.
Duloxetine Duloxetine The risk or severity of gastrointestinal bleeding can be increased when Duloxetine is combined with Indomethacin.
Tinidazole Tinidazole Indomethacin may decrease the excretion rate of Tinidazole which could result in a higher serum level.
Bosentan Bosentan Bosentan may decrease the excretion rate of Indomethacin which could result in a higher serum level.
Cefditoren Cefditoren The excretion of Cefdinir can be decreased when combined with Indomethacin.
Natalizumab Injection Natalizumab Injection The risk or severity of adverse effects can be increased when Indomethacin is combined with Natalizumab.
Cyanocobalamin Injection Cyanocobalamin Injection Indomethacin may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.
Erlotinib Erlotinib The metabolism of Indomethacin can be decreased when combined with Erlotinib.
Eszopiclone Eszopiclone Indomethacin may decrease the excretion rate of Eszopiclone which could result in a higher serum level.
Ganciclovir Ganciclovir Indomethacin may decrease the excretion rate of Ganciclovir which could result in a higher serum level.
Insulin Aspart (rDNA Origin) Injection Insulin Aspart (rDNA Origin) Injection The risk or severity of hypoglycemia can be increased when Indomethacin is combined with Insulin aspart.
Palifermin Palifermin The therapeutic efficacy of Palifermin can be decreased when used in combination with Indomethacin.
Ribavirin Ribavirin Indomethacin may decrease the excretion rate of Ribavirin which could result in a higher serum level.
Solifenacin Solifenacin The risk or severity of hypertension can be increased when Indomethacin is combined with Solifenacin.
Valganciclovir Valganciclovir Indomethacin may decrease the excretion rate of Valganciclovir which could result in a higher serum level.
Voriconazole Voriconazole The metabolism of Indomethacin can be decreased when combined with Voriconazole.
Zoledronic Acid Injection Zoledronic Acid Injection The risk or severity of gastrointestinal bleeding can be increased when Indomethacin is combined with Zoledronic acid.
Adefovir Adefovir The risk or severity of nephrotoxicity can be increased when Indomethacin is combined with Adefovir.
Dextroamphetamine Dextroamphetamine Indomethacin may decrease the excretion rate of Amphetamine which could result in a higher serum level.
Peginterferon Alfa-2a Injection Peginterferon Alfa-2a Injection The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Indomethacin.
Peginterferon Alfa-2b (PEG-Intron) Peginterferon Alfa-2b (PEG-Intron) The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Indomethacin.
Pramlintide Injection Pramlintide Injection The risk or severity of hypoglycemia can be increased when Indomethacin is combined with Pramlintide.
Exenatide Injection Exenatide Injection The risk or severity of hypoglycemia can be increased when Indomethacin is combined with Exenatide.
Ibandronate Ibandronate The risk or severity of gastrointestinal bleeding can be increased when Indomethacin is combined with Ibandronate.
Isocarboxazid Isocarboxazid The risk or severity of hypertension can be increased when Indomethacin is combined with Isocarboxazid.
Ramelteon Ramelteon Indomethacin may decrease the excretion rate of Ramelteon which could result in a higher serum level.
Fentanyl Fentanyl Indomethacin may decrease the excretion rate of Fentanyl which could result in a higher serum level.
Pregabalin Pregabalin Indomethacin may decrease the excretion rate of Pregabalin which could result in a higher serum level.
Deferasirox Deferasirox The risk or severity of gastrointestinal bleeding and peptic ulcer can be increased when Indomethacin is combined with Deferasirox.
Phenylephrine Phenylephrine The risk or severity of hypertension can be increased when Indomethacin is combined with Phenylephrine.
Tipranavir Tipranavir The metabolism of Indomethacin can be increased when combined with Tipranavir.
Felbamate Felbamate The metabolism of Indomethacin can be decreased when combined with Felbamate.
Insulin Detemir (rDNA Origin) Injection Insulin Detemir (rDNA Origin) Injection The risk or severity of hypoglycemia can be increased when Indomethacin is combined with Insulin detemir.
Ranolazine Ranolazine Ranolazine may decrease the excretion rate of Indomethacin which could result in a higher serum level.
Abatacept Injection Abatacept Injection The metabolism of Indomethacin can be increased when combined with Abatacept.
Rasagiline Rasagiline Indomethacin may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Imatinib Imatinib The risk or severity of adverse effects can be increased when Indomethacin is combined with Imatinib.
Sitagliptin Sitagliptin The excretion of Sitagliptin can be decreased when combined with Indomethacin.
Varenicline Varenicline Indomethacin may decrease the excretion rate of Varenicline which could result in a higher serum level.
Bevacizumab Injection Bevacizumab Injection The risk or severity of adverse effects can be increased when Bevacizumab is combined with Indomethacin.
Gefitinib Gefitinib The metabolism of Indomethacin can be decreased when combined with Gefitinib.
Albuterol Albuterol Indomethacin may decrease the excretion rate of Salbutamol which could result in a higher serum level.
Paliperidone Paliperidone Indomethacin may decrease the excretion rate of Paliperidone which could result in a higher serum level.
Bortezomib Bortezomib The risk or severity of adverse effects can be increased when Bortezomib is combined with Indomethacin.
Clofarabine Injection Clofarabine Injection The risk or severity of adverse effects can be increased when Indomethacin is combined with Clofarabine.
Hepatitis B Vaccine Hepatitis B Vaccine The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Indomethacin.
Influenza Vaccine, Inactivated or Recombinant Influenza Vaccine, Inactivated or Recombinant The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Indomethacin.
Influenza Vaccine, Live Intranasal Influenza Vaccine, Live Intranasal The risk or severity of infection can be increased when Typhoid Vaccine Live is combined with Indomethacin.
Live Shingles (Zoster) Vaccine (ZVL) Live Shingles (Zoster) Vaccine (ZVL) The risk or severity of infection can be increased when Varicella Zoster Vaccine (Live/attenuated) is combined with Indomethacin.
Fulvestrant Injection Fulvestrant Injection The metabolism of Fulvestrant can be decreased when combined with Indomethacin.
Insulin Glulisine (rDNA origin) Injection Insulin Glulisine (rDNA origin) Injection The risk or severity of hypoglycemia can be increased when Indomethacin is combined with Insulin glulisine.
Lubiprostone Lubiprostone Indomethacin may decrease the excretion rate of Lubiprostone which could result in a higher serum level.
Oxaliplatin Injection Oxaliplatin Injection The risk or severity of adverse effects can be increased when Indomethacin is combined with Oxaliplatin.
Rituximab Injection Rituximab Injection The risk or severity of adverse effects can be increased when Rituximab is combined with Indomethacin.
Aliskiren Aliskiren The risk or severity of renal failure and hypertension can be increased when Indomethacin is combined with Aliskiren.
Bismuth Subsalicylate Bismuth Subsalicylate The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Indomethacin.
Pemetrexed Injection Pemetrexed Injection Indomethacin may decrease the excretion rate of Pemetrexed which could result in a higher serum level.
Lisdexamfetamine Lisdexamfetamine The risk or severity of hypertension can be increased when Indomethacin is combined with Lisdexamfetamine.
Nabilone Nabilone The metabolism of Indomethacin can be decreased when combined with Nabilone.
Vorinostat Vorinostat The risk or severity of adverse effects can be increased when Indomethacin is combined with Vorinostat.
Sorafenib Sorafenib The metabolism of Indomethacin can be decreased when combined with Sorafenib.
Sunitinib Sunitinib The risk or severity of adverse effects can be increased when Indomethacin is combined with Sunitinib.
Dronabinol Dronabinol The metabolism of Dronabinol can be decreased when combined with Indomethacin.
Lapatinib Lapatinib The metabolism of Lapatinib can be decreased when combined with Indomethacin.
Levocetirizine Levocetirizine Indomethacin may decrease the excretion rate of Levocetirizine which could result in a higher serum level.
Pegaptanib Injection Pegaptanib Injection Indomethacin may decrease the excretion rate of Pegaptanib which could result in a higher serum level.
Dasatinib Dasatinib The risk or severity of adverse effects can be increased when Indomethacin is combined with Dasatinib.
Armodafinil Armodafinil The metabolism of Indomethacin can be decreased when combined with Armodafinil.
Azacitidine Injection Azacitidine Injection The risk or severity of adverse effects can be increased when Indomethacin is combined with Azacitidine.
Temsirolimus Temsirolimus The risk or severity of adverse effects can be increased when Indomethacin is combined with Temsirolimus.
Nelarabine Injection Nelarabine Injection The risk or severity of adverse effects can be increased when Indomethacin is combined with Nelarabine.
Lenalidomide Lenalidomide The risk or severity of adverse effects can be increased when Indomethacin is combined with Lenalidomide.
Nilotinib Nilotinib The risk or severity of adverse effects can be increased when Indomethacin is combined with Nilotinib.
Raltegravir Raltegravir The metabolism of Raltegravir can be decreased when combined with Indomethacin.
Bexarotene Bexarotene The risk or severity of adverse effects can be increased when Bexarotene is combined with Indomethacin.
Budesonide Budesonide The risk or severity of gastrointestinal irritation can be increased when Indomethacin is combined with Budesonide.
Chloramphenicol Injection Chloramphenicol Injection The risk or severity of adverse effects can be increased when Indomethacin is combined with Chloramphenicol.
Decitabine Injection Decitabine Injection The risk or severity of adverse effects can be increased when Indomethacin is combined with Decitabine.
Desmopressin Desmopressin The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Indomethacin is combined with Desmopressin.
Doripenem Injection Doripenem Injection Indomethacin may decrease the excretion rate of Doripenem which could result in a higher serum level.
Etravirine Etravirine The metabolism of Indomethacin can be decreased when combined with Etravirine.
Arsenic Trioxide Injection Arsenic Trioxide Injection The risk or severity of adverse effects can be increased when Indomethacin is combined with Arsenic trioxide.
Mitoxantrone Injection Mitoxantrone Injection The risk or severity of adverse effects can be increased when Indomethacin is combined with Mitoxantrone.
Desvenlafaxine Desvenlafaxine The risk or severity of gastrointestinal bleeding can be increased when Desvenlafaxine is combined with Indomethacin.
Cevimeline Cevimeline Indomethacin may decrease the excretion rate of Cevimeline which could result in a higher serum level.
Nebivolol Nebivolol Indomethacin may decrease the antihypertensive activities of Nebivolol.
Tretinoin Tretinoin The risk or severity of adverse effects can be increased when Indomethacin is combined with Tretinoin.
Bendamustine Injection Bendamustine Injection The risk or severity of adverse effects can be increased when Indomethacin is combined with Bendamustine.
Leucovorin Injection Leucovorin Injection The excretion of Leucovorin can be decreased when combined with Indomethacin.
Flecainide Flecainide The metabolism of Indomethacin can be decreased when combined with Flecainide.
Certolizumab Injection Certolizumab Injection The metabolism of Indomethacin can be increased when combined with Certolizumab pegol.
Ixabepilone Injection Ixabepilone Injection The risk or severity of adverse effects can be increased when Indomethacin is combined with Ixabepilone.
Irinotecan Injection Irinotecan Injection The risk or severity of neutropenia can be increased when Indomethacin is combined with Irinotecan.
Daptomycin Injection Daptomycin Injection Indomethacin may decrease the excretion rate of Daptomycin which could result in a higher serum level.
Estramustine Estramustine The risk or severity of adverse effects can be increased when Indomethacin is combined with Estramustine.
Praziquantel Praziquantel The metabolism of Praziquantel can be decreased when combined with Indomethacin.
Methylnaltrexone Injection Methylnaltrexone Injection Indomethacin may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.
Alemtuzumab Injection (Chronic Lymphocytic Leukemia) Alemtuzumab Injection (Chronic Lymphocytic Leukemia) The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Indomethacin.
Silodosin Silodosin The metabolism of Silodosin can be decreased when combined with Indomethacin.
Midazolam Midazolam Indomethacin may decrease the excretion rate of Midazolam which could result in a higher serum level.
Naltrexone Injection Naltrexone Injection The metabolism of Naltrexone can be decreased when combined with Indomethacin.
Dexrazoxane Injection Dexrazoxane Injection The risk or severity of adverse effects can be increased when Indomethacin is combined with Dexrazoxane.
Eltrombopag Eltrombopag The metabolism of Eltrombopag can be decreased when combined with Indomethacin.
Ibritumomab Injection Ibritumomab Injection The risk or severity of adverse effects can be increased when Ibritumomab tiuxetan is combined with Indomethacin.
Milnacipran Milnacipran The risk or severity of gastrointestinal bleeding can be increased when Milnacipran is combined with Indomethacin.
Dexlansoprazole Dexlansoprazole The metabolism of Dexlansoprazole can be decreased when combined with Indomethacin.
Plerixafor Injection Plerixafor Injection Indomethacin may decrease the excretion rate of Plerixafor which could result in a higher serum level.
Sodium Phosphate Sodium Phosphate The risk or severity of renal failure can be increased when Sodium phosphate, monobasic is combined with Indomethacin.
Fesoterodine Fesoterodine Indomethacin may decrease the excretion rate of Fesoterodine which could result in a higher serum level.
Betaxolol Betaxolol Indomethacin may decrease the antihypertensive activities of Betaxolol.
Iloperidone Iloperidone The risk or severity of hypertension can be increased when Indomethacin is combined with Iloperidone.
Prasugrel Prasugrel The risk or severity of bleeding and hemorrhage can be increased when Indomethacin is combined with Prasugrel.
Lacosamide Lacosamide The metabolism of Lacosamide can be decreased when combined with Indomethacin.
Everolimus Everolimus The risk or severity of adverse effects can be increased when Indomethacin is combined with Everolimus.
Tolvaptan (low blood sodium) Tolvaptan (low blood sodium) The risk or severity of hyperkalemia can be increased when Indomethacin is combined with Tolvaptan.
Dronedarone Dronedarone The excretion of Indomethacin can be decreased when combined with Dronedarone.
Pralatrexate Injection Pralatrexate Injection Indomethacin may decrease the excretion rate of Pralatrexate which could result in a higher serum level.
Palonosetron Injection Palonosetron Injection Indomethacin may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Saxagliptin Saxagliptin Indomethacin may decrease the excretion rate of Saxagliptin which could result in a higher serum level.
Telavancin Injection Telavancin Injection Indomethacin may decrease the excretion rate of Telavancin which could result in a higher serum level.
Tapentadol Tapentadol The metabolism of Tapentadol can be decreased when combined with Indomethacin.
Topotecan Topotecan The risk or severity of adverse effects can be increased when Indomethacin is combined with Topotecan.
Golimumab Injection Golimumab Injection The metabolism of Indomethacin can be increased when combined with Golimumab.
Pazopanib Pazopanib The risk or severity of adverse effects can be increased when Indomethacin is combined with Pazopanib.
Asenapine Asenapine The risk or severity of hypertension can be increased when Indomethacin is combined with Asenapine.
Pitavastatin Pitavastatin The metabolism of Pitavastatin can be decreased when combined with Indomethacin.
Albendazole Albendazole The metabolism of Albendazole can be decreased when combined with Indomethacin.
Denosumab Injection Denosumab Injection The risk or severity of adverse effects can be increased when Denosumab is combined with Indomethacin.
Dabigatran Dabigatran The risk or severity of bleeding and hemorrhage can be increased when Indomethacin is combined with Dabigatran.
Liraglutide Injection Liraglutide Injection The risk or severity of hypoglycemia can be increased when Indomethacin is combined with Liraglutide.
Tocilizumab Injection Tocilizumab Injection The metabolism of Indomethacin can be increased when combined with Tocilizumab.
Dalfampridine Dalfampridine Indomethacin may decrease the excretion rate of Dalfampridine which could result in a higher serum level.
Fingolimod Fingolimod Indomethacin may increase the immunosuppressive activities of Fingolimod.
Eribulin Injection Eribulin Injection The risk or severity of adverse effects can be increased when Indomethacin is combined with Eribulin.
Cabazitaxel Injection Cabazitaxel Injection The risk or severity of adverse effects can be increased when Indomethacin is combined with Cabazitaxel.
Ceftaroline Injection Ceftaroline Injection The risk or severity of nephrotoxicity can be increased when Indomethacin is combined with Ceftaroline fosamil.
Lurasidone Lurasidone The risk or severity of hypertension can be increased when Indomethacin is combined with Lurasidone.
Acetaminophen Injection Acetaminophen Injection The risk or severity of adverse effects can be increased when Acetaminophen is combined with Indomethacin.
Vilazodone Vilazodone The metabolism of Vilazodone can be decreased when combined with Indomethacin.
Ipilimumab Injection Ipilimumab Injection Indomethacin may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Denileukin Diftitox Injection Denileukin Diftitox Injection The risk or severity of adverse effects can be increased when Aldesleukin is combined with Indomethacin.
Sipuleucel-T Injection Sipuleucel-T Injection The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Indomethacin.
Terbutaline Injection Terbutaline Injection Indomethacin may decrease the excretion rate of Terbutaline which could result in a higher serum level.
Belimumab Injection Belimumab Injection The risk or severity of adverse effects can be increased when Indomethacin is combined with Belimumab.
Azilsartan Azilsartan The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Azilsartan medoxomil is combined with Indomethacin.
Busulfan Injection Busulfan Injection The risk or severity of adverse effects can be increased when Indomethacin is combined with Busulfan.
Roflumilast Roflumilast Roflumilast may increase the immunosuppressive activities of Indomethacin.
Linagliptin Linagliptin The risk or severity of hypoglycemia can be increased when Indomethacin is combined with Linagliptin.
Telaprevir Telaprevir The metabolism of Indomethacin can be decreased when combined with Glecaprevir.
Potassium Iodide Potassium Iodide Potassium Iodide may increase the hyperkalemic activities of Indomethacin.
Cyclophosphamide Injection Cyclophosphamide Injection The metabolism of Cyclophosphamide can be decreased when combined with Indomethacin.
Abiraterone Abiraterone The metabolism of Indomethacin can be decreased when combined with Abiraterone.
Rivaroxaban Rivaroxaban The risk or severity of bleeding and hemorrhage can be increased when Indomethacin is combined with Rivaroxaban.
Ticagrelor Ticagrelor The risk or severity of bleeding and hemorrhage can be increased when Indomethacin is combined with Ticagrelor.
Brentuximab Vedotin Injection Brentuximab Vedotin Injection The risk or severity of adverse effects can be increased when Indomethacin is combined with Brentuximab vedotin.
Ruxolitinib Ruxolitinib The risk or severity of adverse effects can be increased when Indomethacin is combined with Ruxolitinib.
Clobazam Clobazam The metabolism of Clobazam can be decreased when combined with Indomethacin.
Vemurafenib Vemurafenib The metabolism of Indomethacin can be decreased when combined with Vemurafenib.
Vismodegib Vismodegib The metabolism of Indomethacin can be decreased when combined with Vismodegib.
Belatacept Injection Belatacept Injection The risk or severity of adverse effects can be increased when Indomethacin is combined with Belatacept.
Basiliximab Injection Basiliximab Injection The risk or severity of adverse effects can be increased when Basiliximab is combined with Indomethacin.
Deferiprone Deferiprone Indomethacin may decrease the excretion rate of Deferiprone which could result in a higher serum level.
Axitinib Axitinib The metabolism of Axitinib can be decreased when combined with Indomethacin.
Melphalan Injection Melphalan Injection The risk or severity of adverse effects can be increased when Indomethacin is combined with Melphalan.
Cabergoline Cabergoline The risk or severity of hypertension can be increased when Cabergoline is combined with Indomethacin.
Naloxone Injection Naloxone Injection Indomethacin may decrease the excretion rate of Naloxone which could result in a higher serum level.
Ambrisentan Ambrisentan The metabolism of Ambrisentan can be decreased when combined with Indomethacin.
Eculizumab Injection Eculizumab Injection The risk or severity of adverse effects can be increased when Indomethacin is combined with Eculizumab.
Fondaparinux Injection Fondaparinux Injection The risk or severity of bleeding and hemorrhage can be increased when Indomethacin is combined with Fondaparinux.
Ezogabine Ezogabine The metabolism of Tiagabine can be decreased when combined with Indomethacin.
Carfilzomib Injection Carfilzomib Injection The risk or severity of adverse effects can be increased when Indomethacin is combined with Carfilzomib.
Iloprost Iloprost The risk or severity of bleeding and hemorrhage can be increased when Indomethacin is combined with Iloprost.
Enzalutamide Enzalutamide The metabolism of Indomethacin can be increased when combined with Enzalutamide.
Mirabegron Mirabegron Indomethacin may decrease the excretion rate of Mirabegron which could result in a higher serum level.
Regorafenib Regorafenib The metabolism of Indomethacin can be decreased when combined with Regorafenib.
Bosutinib Bosutinib The risk or severity of adverse effects can be increased when Indomethacin is combined with Bosutinib.
Corticotropin, Repository Injection Corticotropin, Repository Injection The risk or severity of gastrointestinal irritation can be increased when Indomethacin is combined with Corticotropin.
Teriflunomide Teriflunomide The risk or severity of adverse effects can be increased when Indomethacin is combined with Teriflunomide.
Lorcaserin Lorcaserin The risk or severity of hypoglycemia can be increased when Indomethacin is combined with Mecasermin.
Cabozantinib (thyroid cancer) Cabozantinib (thyroid cancer) The metabolism of Cabozantinib can be decreased when combined with Indomethacin.
Teduglutide Injection Teduglutide Injection Indomethacin may decrease the excretion rate of Teduglutide which could result in a higher serum level.
Icosapent Ethyl Icosapent Ethyl The risk or severity of bleeding can be increased when Indomethacin is combined with Icosapent ethyl.
Tofacitinib Tofacitinib Indomethacin may increase the immunosuppressive activities of Tofacitinib.
Alogliptin Alogliptin Indomethacin may decrease the excretion rate of Alogliptin which could result in a higher serum level.
Dimethyl Fumarate Dimethyl Fumarate The risk or severity of adverse effects can be increased when Indomethacin is combined with Dimethyl fumarate.
Ponatinib Ponatinib The risk or severity of adverse effects can be increased when Indomethacin is combined with Ponatinib.
Pomalidomide Pomalidomide The risk or severity of adverse effects can be increased when Indomethacin is combined with Pomalidomide.
Ado-trastuzumab Emtansine Injection Ado-trastuzumab Emtansine Injection The risk or severity of adverse effects can be increased when Indomethacin is combined with Trastuzumab emtansine.
Apixaban Apixaban The risk or severity of bleeding and hemorrhage can be increased when Indomethacin is combined with Apixaban.
Canagliflozin Canagliflozin The risk or severity of hypoglycemia can be increased when Indomethacin is combined with Canagliflozin.
Methazolamide Methazolamide The excretion of Indomethacin can be decreased when combined with Methazolamide.
Dabrafenib Dabrafenib The metabolism of Indomethacin can be increased when combined with Dabrafenib.
Ospemifene Ospemifene The metabolism of Ospemifene can be decreased when combined with Indomethacin.
Trametinib Trametinib Indomethacin may decrease the excretion rate of Trametinib which could result in a higher serum level.
Dolutegravir Dolutegravir The excretion of Indomethacin can be decreased when combined with Dolutegravir.
Levomilnacipran Levomilnacipran The risk or severity of gastrointestinal bleeding can be increased when Indomethacin is combined with Levomilnacipran.
Ertapenem Injection Ertapenem Injection Indomethacin may decrease the excretion rate of Ertapenem which could result in a higher serum level.
Vortioxetine Vortioxetine Indomethacin may decrease the excretion rate of Vortioxetine which could result in a higher serum level.
Ibrutinib Ibrutinib The risk or severity of adverse effects can be increased when Indomethacin is combined with Ibrutinib.
Ketorolac Injection Ketorolac Injection The risk or severity of adverse effects can be increased when Ketorolac is combined with Indomethacin.
Obinutuzumab Injection Obinutuzumab Injection The risk or severity of adverse effects can be increased when Indomethacin is combined with Obinutuzumab.
Simeprevir Simeprevir Simeprevir may decrease the excretion rate of Indomethacin which could result in a higher serum level.
Sofosbuvir Sofosbuvir Indomethacin may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.
Dapagliflozin Dapagliflozin The metabolism of Dapagliflozin can be decreased when combined with Indomethacin.
Apremilast Apremilast The metabolism of Indomethacin can be increased when combined with Apremilast.
Droxidopa Droxidopa Indomethacin may decrease the excretion rate of Droxidopa which could result in a higher serum level.
Ceritinib Ceritinib The metabolism of Indomethacin can be decreased when combined with Ceritinib.
Siltuximab Injection Siltuximab Injection The metabolism of Indomethacin can be increased when combined with Siltuximab.
Albiglutide Injection Albiglutide Injection The risk or severity of hypoglycemia can be increased when Indomethacin is combined with Albiglutide.
Eslicarbazepine Eslicarbazepine The metabolism of Eslicarbazepine can be decreased when combined with Indomethacin.
Vedolizumab Injection Vedolizumab Injection The risk or severity of adverse effects can be increased when Indomethacin is combined with Vedolizumab.
Belinostat Injection Belinostat Injection The metabolism of Belinostat can be decreased when combined with Indomethacin.
Idelalisib Idelalisib The risk or severity of adverse effects can be increased when Indomethacin is combined with Idelalisib.
Testosterone Injection Testosterone Injection The metabolism of Testosterone can be decreased when combined with Indomethacin.
Oritavancin Injection Oritavancin Injection The metabolism of Indomethacin can be decreased when combined with Oritavancin.
Empagliflozin Empagliflozin The risk or severity of hypoglycemia can be increased when Indomethacin is combined with Empagliflozin.
Vorapaxar Vorapaxar The risk or severity of bleeding and hemorrhage can be increased when Indomethacin is combined with Vorapaxar.
Dulaglutide Injection Dulaglutide Injection The risk or severity of hypoglycemia can be increased when Indomethacin is combined with Dulaglutide.
Edoxaban Edoxaban The risk or severity of bleeding and hemorrhage can be increased when Indomethacin is combined with Edoxaban.
Peginterferon Beta-1a Injection Peginterferon Beta-1a Injection The risk or severity of adverse effects can be increased when Indomethacin is combined with Peginterferon beta-1a.
Olaparib Olaparib The risk or severity of adverse effects can be increased when Indomethacin is combined with Olaparib.
Blinatumomab Injection Blinatumomab Injection The risk or severity of adverse effects can be increased when Indomethacin is combined with Blinatumomab.
Caspofungin Injection Caspofungin Injection The excretion of Caspofungin can be decreased when combined with Indomethacin.
Methamphetamine Methamphetamine Indomethacin may decrease the excretion rate of Metamfetamine which could result in a higher serum level.
Tasimelteon Tasimelteon Indomethacin may decrease the excretion rate of Tasimelteon which could result in a higher serum level.
Riociguat Riociguat The therapeutic efficacy of Riociguat can be decreased when used in combination with Indomethacin.
Lanreotide Injection Lanreotide Injection The risk or severity of hypoglycemia can be increased when Indomethacin is combined with Lanreotide.
Pirfenidone Pirfenidone The risk or severity of adverse effects can be increased when Indomethacin is combined with Pirfenidone.
Nintedanib Nintedanib The metabolism of Nintedanib can be decreased when combined with Indomethacin.
Secukinumab Injection Secukinumab Injection The metabolism of Indomethacin can be increased when combined with Secukinumab.
Risperidone Injection Risperidone Injection The risk or severity of hypertension can be increased when Indomethacin is combined with Risperidone.
Palbociclib Palbociclib The risk or severity of adverse effects can be increased when Indomethacin is combined with Palbociclib.
Insulin Human Inhalation Insulin Human Inhalation The risk or severity of hypoglycemia can be increased when Insulin human is combined with Indomethacin.
Lenvatinib Lenvatinib Lenvatinib may decrease the excretion rate of Indomethacin which could result in a higher serum level.
Panobinostat Panobinostat The risk or severity of adverse effects can be increased when Indomethacin is combined with Panobinostat.
Dinutuximab Injection Dinutuximab Injection The risk or severity of adverse effects can be increased when Indomethacin is combined with Dinutuximab.
Haloperidol Injection Haloperidol Injection The therapeutic efficacy of Haloperidol can be increased when used in combination with Indomethacin.
Deoxycholic Acid Injection Deoxycholic Acid Injection Deoxycholic acid may increase the excretion rate of Indomethacin which could result in a lower serum level and potentially a reduction in efficacy.
Amiloride Amiloride The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Indomethacin is combined with Amiloride.
Macitentan Macitentan The therapeutic efficacy of Macitentan can be decreased when used in combination with Indomethacin.
Flibanserin Flibanserin The risk or severity of hypertension can be increased when Indomethacin is combined with Flibanserin.
Prednisolone Prednisolone The risk or severity of gastrointestinal irritation can be increased when Indomethacin is combined with Prednisolone.
Brexpiprazole Brexpiprazole The risk or severity of hypertension can be increased when Indomethacin is combined with Brexpiprazole.
Ziprasidone Injection Ziprasidone Injection The risk or severity of hypertension can be increased when Ziprasidone is combined with Indomethacin.
Cariprazine Cariprazine The risk or severity of hypertension can be increased when Indomethacin is combined with Cariprazine.
Penicillin G Procaine Injection Penicillin G Procaine Injection Indomethacin may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.
Eluxadoline Eluxadoline The serum concentration of Eluxadoline can be increased when it is combined with Indomethacin.
Insulin Degludec (rDNA Origin) Injection Insulin Degludec (rDNA Origin) Injection The risk or severity of hypoglycemia can be increased when Indomethacin is combined with Insulin degludec.
Cobimetinib Cobimetinib The excretion of Cobimetinib can be decreased when combined with Indomethacin.
Mepolizumab Injection Mepolizumab Injection The risk or severity of adverse effects can be increased when Indomethacin is combined with Mepolizumab.
Trabectedin Injection Trabectedin Injection The metabolism of Trabectedin can be decreased when combined with Indomethacin.
Ixazomib Ixazomib Indomethacin may decrease the excretion rate of Ixazomib which could result in a higher serum level.
Lesinurad Lesinurad Indomethacin may decrease the excretion rate of Lesinurad which could result in a higher serum level.
Amphotericin B Liposomal Injection Amphotericin B Liposomal Injection The risk or severity of nephrotoxicity can be increased when Indomethacin is combined with Amphotericin B.
Dexamethasone Injection Dexamethasone Injection The risk or severity of gastrointestinal irritation can be increased when Indomethacin is combined with Dexamethasone.
Defibrotide Injection Defibrotide Injection The risk or severity of bleeding and hemorrhage can be increased when Indomethacin is combined with Defibrotide.
Ixekizumab Injection Ixekizumab Injection The risk or severity of adverse effects can be increased when Indomethacin is combined with Ixekizumab.
Brivaracetam Injection Brivaracetam Injection Indomethacin may decrease the excretion rate of Brivaracetam which could result in a higher serum level.
Midodrine Midodrine The risk or severity of hypertension can be increased when Midodrine is combined with Indomethacin.
Selexipag Selexipag The therapeutic efficacy of Selexipag can be decreased when used in combination with Indomethacin.
Diphenhydramine Injection Diphenhydramine Injection The metabolism of Diphenhydramine can be decreased when combined with Indomethacin.
Furosemide Injection Furosemide Injection The therapeutic efficacy of Furosemide can be decreased when used in combination with Indomethacin.
Rucaparib Rucaparib The metabolism of Indomethacin can be decreased when combined with Rucaparib.
Lixisenatide Injection Lixisenatide Injection Indomethacin may decrease the excretion rate of Lixisenatide which could result in a higher serum level.
Brodalumab Injection Brodalumab Injection The risk or severity of adverse effects can be increased when Indomethacin is combined with Brodalumab.
Doxepin (Insomnia) Doxepin (Insomnia) The metabolism of Doxepin can be decreased when combined with Indomethacin.
Deutetrabenazine Deutetrabenazine Indomethacin may decrease the excretion rate of Deutetrabenazine which could result in a higher serum level.
Valbenazine Valbenazine Indomethacin may decrease the excretion rate of Valbenazine which could result in a higher serum level.
Deflazacort Deflazacort The risk or severity of gastrointestinal irritation can be increased when Indomethacin is combined with Deflazacort.
Safinamide Safinamide The metabolism of Indomethacin can be decreased when combined with Safinamide.
Ocrelizumab Injection Ocrelizumab Injection Ocrelizumab may increase the immunosuppressive activities of Indomethacin.
Edaravone Injection Edaravone Injection The excretion of Edaravone can be decreased when combined with Indomethacin.
Naldemedine Naldemedine Indomethacin may decrease the excretion rate of Naldemedine which could result in a higher serum level.
Sarilumab Injection Sarilumab Injection The risk or severity of adverse effects can be increased when Indomethacin is combined with Sarilumab.
Midostaurin Midostaurin The metabolism of Indomethacin can be decreased when combined with Midostaurin.
Guselkumab Injection Guselkumab Injection The risk or severity of adverse effects can be increased when Indomethacin is combined with Guselkumab.
Enasidenib Enasidenib The metabolism of Enasidenib can be decreased when combined with Indomethacin.
Benznidazole Benznidazole Indomethacin may decrease the excretion rate of Benznidazole which could result in a higher serum level.
Delafloxacin Delafloxacin Indomethacin may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Betrixaban Betrixaban The risk or severity of bleeding can be increased when Indomethacin is combined with Betrixaban.
Gemtuzumab Ozogamicin Injection Gemtuzumab Ozogamicin Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Indomethacin.
Letermovir Letermovir Letermovir may decrease the excretion rate of Indomethacin which could result in a higher serum level.
Semaglutide Injection Semaglutide Injection The risk or severity of hypoglycemia can be increased when Indomethacin is combined with Semaglutide.
Ertugliflozin Ertugliflozin The metabolism of Ertugliflozin can be decreased when combined with Indomethacin.
Buprenorphine Injection Buprenorphine Injection The metabolism of Buprenorphine can be decreased when combined with Indomethacin.
Apalutamide Apalutamide The excretion of Indomethacin can be decreased when combined with Apalutamide.
Penicillamine Penicillamine The risk or severity of adverse effects can be increased when Indomethacin is combined with Penicillamine.
Fostamatinib Fostamatinib The metabolism of Indomethacin can be decreased when combined with Fostamatinib.
Avatrombopag Avatrombopag The excretion of Indomethacin can be decreased when combined with Avatrombopag.
Baricitinib Baricitinib The risk or severity of adverse effects can be increased when Indomethacin is combined with Baricitinib.
Lofexidine Lofexidine The therapeutic efficacy of Lofexidine can be decreased when used in combination with Indomethacin.
Plazomicin Injection Plazomicin Injection Indomethacin may decrease the excretion rate of Plazomicin which could result in a higher serum level.
Binimetinib Binimetinib The metabolism of Binimetinib can be decreased when combined with Indomethacin.
Ivosidenib Ivosidenib The excretion of Indomethacin can be decreased when combined with Ivosidenib.
Elagolix Elagolix The metabolism of Elagolix can be decreased when combined with Indomethacin.
Cannabidiol Cannabidiol The metabolism of Cannabidiol can be decreased when combined with Indomethacin.
Dacomitinib Dacomitinib The metabolism of Indomethacin can be decreased when combined with Dacomitinib.
Stiripentol Stiripentol Indomethacin may decrease the excretion rate of Stiripentol which could result in a higher serum level.
Lorlatinib Lorlatinib The metabolism of Lorlatinib can be decreased when combined with Indomethacin.
Paclitaxel (with albumin) Injection Paclitaxel (with albumin) Injection The risk or severity of adverse effects can be increased when Indomethacin is combined with Paclitaxel.
Rifamycin Rifamycin The metabolism of Indomethacin can be decreased when combined with Rifamycin.
Prucalopride Prucalopride Indomethacin may decrease the excretion rate of Prucalopride which could result in a higher serum level.
Ravulizumab-cwvz Injection Ravulizumab-cwvz Injection The risk or severity of adverse effects can be increased when Indomethacin is combined with Ravulizumab.
Emapalumab-lzsg Injection Emapalumab-lzsg Injection The metabolism of Indomethacin can be increased when combined with Emapalumab.
Siponimod Siponimod The metabolism of Siponimod can be decreased when combined with Indomethacin.
Acyclovir Ophthalmic Acyclovir Ophthalmic Indomethacin may decrease the excretion rate of Acyclovir which could result in a higher serum level.
Caplacizumab-yhdp Injection Caplacizumab-yhdp Injection The risk or severity of bleeding can be increased when Indomethacin is combined with Caplacizumab.
Erdafitinib Erdafitinib The metabolism of Erdafitinib can be decreased when combined with Indomethacin.
Esomeprazole Injection Esomeprazole Injection The excretion of Indomethacin can be decreased when combined with Esomeprazole.
Risankizumab-rzaa Injection Risankizumab-rzaa Injection The risk or severity of adverse effects can be increased when Indomethacin is combined with Risankizumab.
Alpelisib Alpelisib The serum concentration of Indomethacin can be decreased when it is combined with Alpelisib.
Cladribine Cladribine The risk or severity of adverse effects can be increased when Cladribine is combined with Indomethacin.
Solriamfetol Solriamfetol The risk or severity of hypertension can be increased when Solriamfetol is combined with Indomethacin.
Darolutamide Darolutamide The metabolism of Darolutamide can be decreased when combined with Indomethacin.
Triclabendazole Triclabendazole The metabolism of Indomethacin can be decreased when combined with Triclabendazole.
Pexidartinib Pexidartinib The metabolism of Indomethacin can be decreased when combined with Pexidartinib.
Istradefylline Istradefylline The metabolism of Istradefylline can be decreased when combined with Indomethacin.
Pitolisant Pitolisant The risk or severity of adverse effects can be increased when Indomethacin is combined with Pitolisant.
Fedratinib Fedratinib The metabolism of Fedratinib can be decreased when combined with Indomethacin.
Phenytoin Injection Phenytoin Injection The serum concentration of Phenytoin can be increased when it is combined with Indomethacin.
Fosphenytoin Injection Fosphenytoin Injection The metabolism of Fosphenytoin can be decreased when combined with Indomethacin.
Voxelotor Voxelotor The metabolism of Voxelotor can be decreased when combined with Indomethacin.
Avapritinib Avapritinib The metabolism of Avapritinib can be decreased when combined with Indomethacin.
Lumateperone Lumateperone The serum concentration of Lumateperone can be increased when it is combined with Indomethacin.
Bempedoic Acid Bempedoic Acid The metabolism of Bempedoic acid can be decreased when combined with Indomethacin.
Cenobamate Cenobamate The metabolism of Cenobamate can be decreased when combined with Indomethacin.
Ozanimod Ozanimod The risk or severity of adverse effects can be increased when Indomethacin is combined with Ozanimod.
Selumetinib Selumetinib The metabolism of Selumetinib can be decreased when combined with Indomethacin.
Remdesivir Injection Remdesivir Injection The excretion of Remdesivir can be decreased when combined with Indomethacin.
Sacituzumab govitecan-hziy Injection Sacituzumab govitecan-hziy Injection The serum concentration of Sacituzumab govitecan can be increased when it is combined with Indomethacin.
Selpercatinib Selpercatinib The risk or severity of hypertension can be increased when Indomethacin is combined with Selpercatinib.
Octreotide Octreotide The risk or severity of hypoglycemia can be increased when Octreotide is combined with Indomethacin.
Belantamab Mafodotin-blmf Injection Belantamab Mafodotin-blmf Injection Indomethacin may decrease the excretion rate of Belantamab mafodotin which could result in a higher serum level.
Pralsetinib Pralsetinib Pralsetinib may decrease the excretion rate of Indomethacin which could result in a higher serum level.
Satralizumab-mwge Injection Satralizumab-mwge Injection The serum concentration of Indomethacin can be decreased when it is combined with Satralizumab.
Naxitamab-gqgk Injection Naxitamab-gqgk Injection The risk or severity of hypertension can be increased when Indomethacin is combined with Naxitamab.
Cabotegravir Cabotegravir The excretion of Indomethacin can be decreased when combined with Cabotegravir.
Progestin-Only (drospirenone) Oral Contraceptives Progestin-Only (drospirenone) Oral Contraceptives The risk or severity of hyperkalemia can be increased when Indomethacin is combined with Drospirenone.
Viloxazine Viloxazine Indomethacin may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Tobramycin Injection Tobramycin Injection Indomethacin may decrease the excretion rate of Tobramycin which could result in a higher serum level.
Fenoprofen Fenoprofen The risk or severity of adverse effects can be increased when Indomethacin is combined with Fenoprofen.
Mefenamic Acid Mefenamic Acid The risk or severity of adverse effects can be increased when Indomethacin is combined with Mefenamic acid.
Naproxen Naproxen The risk or severity of adverse effects can be increased when Indomethacin is combined with Naproxen.
Tolmetin Tolmetin The risk or severity of adverse effects can be increased when Indomethacin is combined with Tolmetin.
Sulindac Sulindac The risk or severity of adverse effects can be increased when Indomethacin is combined with Sulindac.
Trazodone Trazodone The risk or severity of gastrointestinal bleeding can be increased when Indomethacin is combined with Trazodone.
Isotretinoin Isotretinoin Indomethacin may decrease the excretion rate of Isotretinoin which could result in a higher serum level.
Sucralfate Sucralfate Indomethacin may decrease the excretion rate of Sucralfate which could result in a higher serum level.
Hydroxyurea Hydroxyurea The risk or severity of adverse effects can be increased when Indomethacin is combined with Hydroxyurea.
Floxuridine Floxuridine The metabolism of Indomethacin can be decreased when combined with Floxuridine.
Phenobarbital Phenobarbital The metabolism of Phenobarbital can be decreased when combined with Indomethacin.
Metaxalone Metaxalone Indomethacin may decrease the excretion rate of Metaxalone which could result in a higher serum level.
Methotrexate Injection Methotrexate Injection The serum concentration of Methotrexate can be increased when it is combined with Indomethacin.
Primidone Primidone The metabolism of Indomethacin can be increased when combined with Primidone.
Methsuximide Methsuximide The metabolism of Methsuximide can be decreased when combined with Indomethacin.
Diethylpropion Diethylpropion The risk or severity of hypertension can be increased when Indomethacin is combined with Diethylpropion.
Chlorpromazine Chlorpromazine Chlorpromazine may decrease the excretion rate of Indomethacin which could result in a higher serum level.
Diazepam Diazepam The metabolism of Diazepam can be decreased when combined with Indomethacin.
Oxazepam Oxazepam Indomethacin may decrease the excretion rate of Oxazepam which could result in a higher serum level.
Flurazepam Flurazepam Indomethacin may decrease the excretion rate of Flurazepam which could result in a higher serum level.
Clorazepate Clorazepate Indomethacin may decrease the excretion rate of Clorazepic acid which could result in a higher serum level.
Lorazepam Lorazepam Indomethacin may decrease the excretion rate of Lorazepam which could result in a higher serum level.
Phenoxybenzamine Phenoxybenzamine The therapeutic efficacy of Phenoxybenzamine can be decreased when used in combination with Indomethacin.
Carmustine Carmustine The risk or severity of adverse effects can be increased when Carmustine is combined with Indomethacin.
Amantadine Amantadine Indomethacin may decrease the excretion rate of Amantadine which could result in a higher serum level.
Codeine Codeine Indomethacin may decrease the excretion rate of Codeine which could result in a higher serum level.
Bromocriptine Bromocriptine The risk or severity of hypoglycemia can be increased when Indomethacin is combined with Bromocriptine.
Metaproterenol Metaproterenol The risk or severity of hypertension can be increased when Indomethacin is combined with Orciprenaline.
Tranylcypromine Tranylcypromine The metabolism of Indomethacin can be decreased when combined with Tranylcypromine.
Phenelzine Phenelzine Indomethacin may decrease the excretion rate of Phenelzine which could result in a higher serum level.
Procarbazine Procarbazine The risk or severity of adverse effects can be increased when Indomethacin is combined with Procarbazine.
Ergoloid Mesylates Ergoloid Mesylates The risk or severity of hypertension can be increased when Indomethacin is combined with Ergoloid mesylate.
Tetracycline Tetracycline The excretion of Tetracycline can be decreased when combined with Indomethacin.
Thioguanine Thioguanine The risk or severity of adverse effects can be increased when Indomethacin is combined with Tioguanine.
Minocycline Minocycline The excretion of Indomethacin can be decreased when combined with Minocycline.
Thioridazine Thioridazine The metabolism of Thioridazine can be decreased when combined with Indomethacin.
Trifluoperazine Trifluoperazine The risk or severity of hypertension can be increased when Indomethacin is combined with Trifluoperazine.
Bleomycin Bleomycin The risk or severity of adverse effects can be increased when Bleomycin is combined with Indomethacin.
Dapsone Dapsone The metabolism of Indomethacin can be decreased when combined with Dapsone.
Sulfadiazine Sulfadiazine Indomethacin may decrease the excretion rate of Sulfadiazine which could result in a higher serum level.
Methadone Methadone The metabolism of Methadone can be decreased when combined with Indomethacin.
Benztropine Benztropine Indomethacin may decrease the excretion rate of Benzatropine which could result in a higher serum level.
Colestipol Colestipol Colestipol can cause a decrease in the absorption of Indomethacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Maprotiline Maprotiline Indomethacin may decrease the excretion rate of Maprotiline which could result in a higher serum level.
Ibuprofen Ibuprofen The risk or severity of adverse effects can be increased when Indomethacin is combined with Ibuprofen.
Azathioprine Azathioprine The risk or severity of adverse effects can be increased when Indomethacin is combined with Azathioprine.
Phentermine Phentermine The risk or severity of hypertension can be increased when Phentermine is combined with Indomethacin.
Methylphenidate Methylphenidate Indomethacin may decrease the excretion rate of Methylphenidate which could result in a higher serum level.
Amoxapine Amoxapine The risk or severity of hypertension can be increased when Indomethacin is combined with Amoxapine.
Sulfasalazine Sulfasalazine The therapeutic efficacy of Sulfasalazine can be decreased when used in combination with Indomethacin.
Hydrocortisone Hydrocortisone The risk or severity of gastrointestinal irritation can be increased when Indomethacin is combined with Hydrocortisone.
Lomustine Lomustine The risk or severity of adverse effects can be increased when Indomethacin is combined with Lomustine.
Doxorubicin Doxorubicin The risk or severity of adverse effects can be increased when Indomethacin is combined with Doxorubicin.
Cytarabine Cytarabine The risk or severity of adverse effects can be increased when Indomethacin is combined with Cytarabine.
Mechlorethamine Mechlorethamine The risk or severity of adverse effects can be increased when Indomethacin is combined with Mechlorethamine.
Dactinomycin Dactinomycin The risk or severity of adverse effects can be increased when Indomethacin is combined with Dactinomycin.
Phenazopyridine Phenazopyridine The risk or severity of nephrotoxicity can be increased when Indomethacin is combined with Phenazopyridine.
Carbamazepine Carbamazepine The risk or severity of adverse effects can be increased when Indomethacin is combined with Carbamazepine.
Methyldopa Methyldopa The therapeutic efficacy of Methyldopa can be decreased when used in combination with Indomethacin.
Clonidine Clonidine The therapeutic efficacy of Clonidine can be decreased when used in combination with Indomethacin.
Prazosin Prazosin The therapeutic efficacy of Prazosin can be decreased when used in combination with Indomethacin.
Hydralazine Hydralazine Indomethacin may decrease the antihypertensive activities of Hydralazine.
Cimetidine Cimetidine Cimetidine may decrease the excretion rate of Indomethacin which could result in a higher serum level.
Gentamicin Injection Gentamicin Injection Indomethacin may decrease the excretion rate of Gentamicin which could result in a higher serum level.
Warfarin Warfarin The risk or severity of bleeding and hemorrhage can be increased when Indomethacin is combined with Warfarin.
Clonazepam Clonazepam Indomethacin may decrease the excretion rate of Clonazepam which could result in a higher serum level.
Loperamide Loperamide The risk or severity of hyperkalemia can be increased when Indomethacin is combined with Loperamide.
Promethazine Promethazine The metabolism of Indomethacin can be decreased when combined with Promethazine.
Meclofenamate Meclofenamate The risk or severity of adverse effects can be increased when Indomethacin is combined with Meclofenamic acid.
Daunorubicin Daunorubicin The risk or severity of adverse effects can be increased when Indomethacin is combined with Daunorubicin.
Nitrofurantoin Nitrofurantoin Indomethacin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.
Digoxin Digoxin The serum concentration of Digoxin can be increased when it is combined with Indomethacin.
Chloroquine Chloroquine Indomethacin may decrease the excretion rate of Chloroquine which could result in a higher serum level.
Quinine Quinine The risk or severity of hypoglycemia can be increased when Indomethacin is combined with Quinine.
Ethosuximide Ethosuximide The risk or severity of hyperkalemia can be increased when Indomethacin is combined with Ethosuximide.
Triamterene Triamterene Indomethacin may increase the nephrotoxic activities of Triamterene.
Sulfinpyrazone Sulfinpyrazone The risk or severity of bleeding can be increased when Indomethacin is combined with Sulfinpyrazone.
Chlorothiazide Chlorothiazide The therapeutic efficacy of Indomethacin can be decreased when used in combination with Chlorothiazide.
Chlorthalidone Chlorthalidone The therapeutic efficacy of Chlorthalidone can be decreased when used in combination with Indomethacin.
Metolazone Metolazone Indomethacin may decrease the excretion rate of Metolazone which could result in a higher serum level.
Secobarbital Secobarbital Indomethacin may decrease the excretion rate of Secobarbital which could result in a higher serum level.
Desipramine Desipramine Indomethacin may decrease the excretion rate of Desipramine which could result in a higher serum level.
Amitriptyline Amitriptyline Amitriptyline may decrease the excretion rate of Indomethacin which could result in a higher serum level.
Imipramine Imipramine The metabolism of Imipramine can be decreased when combined with Indomethacin.
Probenecid Probenecid Probenecid may decrease the excretion rate of Indomethacin which could result in a higher serum level.
Quinidine Quinidine Quinidine may decrease the excretion rate of Indomethacin which could result in a higher serum level.
Procainamide Procainamide Indomethacin may decrease the excretion rate of Procainamide which could result in a higher serum level.
Isoniazid Isoniazid Indomethacin may decrease the excretion rate of Isoniazid which could result in a higher serum level.
Pyrazinamide Pyrazinamide Indomethacin may decrease the excretion rate of Pyrazinamide which could result in a higher serum level.
Rifampin Rifampin The excretion of Indomethacin can be decreased when combined with Rifampicin.
Disopyramide Disopyramide Indomethacin may decrease the excretion rate of Disopyramide which could result in a higher serum level.
Valproic Acid Valproic Acid The protein binding of Valproic acid can be decreased when combined with Indomethacin.
Tamoxifen Tamoxifen The metabolism of Indomethacin can be decreased when combined with Tamoxifen.
Mitomycin Mitomycin The risk or severity of adverse effects can be increased when Mitomycin is combined with Indomethacin.
Butabarbital Butabarbital Indomethacin may decrease the excretion rate of Butabarbital which could result in a higher serum level.
Levothyroxine Levothyroxine The metabolism of Levothyroxine can be decreased when combined with Indomethacin.
Liothyronine Liothyronine Indomethacin may decrease the excretion rate of Liothyronine which could result in a higher serum level.
Methimazole Methimazole The risk or severity of adverse effects can be increased when Indomethacin is combined with Methimazole.
Propylthiouracil Propylthiouracil The risk or severity of adverse effects can be increased when Indomethacin is combined with Propylthiouracil.
Chlorpropamide Chlorpropamide The protein binding of Chlorpropamide can be decreased when combined with Indomethacin.
Glucagon Injection Glucagon Injection The therapeutic efficacy of Glucagon can be decreased when used in combination with Indomethacin.
Tolbutamide Tolbutamide The protein binding of Tolbutamide can be decreased when combined with Indomethacin.
Tolazamide Tolazamide The protein binding of Tolazamide can be decreased when combined with Indomethacin.
Dextromethorphan Dextromethorphan The metabolism of Dextromethorphan can be decreased when combined with Indomethacin.
Dinoprostone Dinoprostone The excretion of Dinoprostone can be decreased when combined with Indomethacin.
Baclofen Baclofen Indomethacin may decrease the excretion rate of Baclofen which could result in a higher serum level.
Ethambutol Ethambutol Indomethacin may decrease the excretion rate of Ethambutol which could result in a higher serum level.
Methyclothiazide Methyclothiazide The therapeutic efficacy of Indomethacin can be decreased when used in combination with Methyclothiazide.
Hydrochlorothiazide Hydrochlorothiazide The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Indomethacin.
Dantrolene Dantrolene The risk or severity of hyperkalemia can be increased when Indomethacin is combined with Dantrolene.
Chlorzoxazone Chlorzoxazone Indomethacin may decrease the excretion rate of Chlorzoxazone which could result in a higher serum level.
Carisoprodol Carisoprodol The metabolism of Carisoprodol can be decreased when combined with Indomethacin.
Pyridoxine Pyridoxine Indomethacin may decrease the excretion rate of Pyridoxine which could result in a higher serum level.
Folic Acid Folic Acid Indomethacin may decrease the excretion rate of Folic acid which could result in a higher serum level.
Disulfiram Disulfiram Indomethacin may decrease the excretion rate of Disulfiram which could result in a higher serum level.
Propranolol (Cardiovascular) Propranolol (Cardiovascular) The serum concentration of Propranolol can be increased when it is combined with Indomethacin.
Minoxidil Minoxidil The therapeutic efficacy of Minoxidil can be decreased when used in combination with Indomethacin.
Pseudoephedrine Pseudoephedrine The risk or severity of hypertension can be increased when Indomethacin is combined with Pseudoephedrine.
Nortriptyline Nortriptyline The risk or severity of hypertension can be increased when Indomethacin is combined with Nortriptyline.
Spironolactone Spironolactone Indomethacin may decrease the excretion rate of Spironolactone which could result in a higher serum level.
Amphotericin B Injection Amphotericin B Injection The risk or severity of nephrotoxicity can be increased when Indomethacin is combined with Amphotericin B.
Mercaptopurine Mercaptopurine The risk or severity of adverse effects can be increased when Indomethacin is combined with Mercaptopurine.
Phytonadione Phytonadione Indomethacin may decrease the excretion rate of Phylloquinone which could result in a higher serum level.
Amikacin Injection Amikacin Injection Indomethacin may decrease the excretion rate of Amikacin which could result in a higher serum level.
Nadolol Nadolol Indomethacin may decrease the antihypertensive activities of Nadolol.
Cholestyramine Resin Cholestyramine Resin Cholestyramine can cause a decrease in the absorption of Indomethacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Allopurinol Allopurinol The risk or severity of adverse effects can be increased when Allopurinol is combined with Indomethacin.
Flavoxate Flavoxate Indomethacin may decrease the excretion rate of Flavoxate which could result in a higher serum level.
Fluorouracil Injection Fluorouracil Injection The risk or severity of adverse effects can be increased when Indomethacin is combined with Fluorouracil.
Colchicine Colchicine The risk or severity of adverse effects can be increased when Indomethacin is combined with Colchicine.
Cefaclor Cefaclor Indomethacin may decrease the excretion rate of Cefaclor which could result in a higher serum level.
Cefadroxil Cefadroxil Indomethacin may decrease the excretion rate of Cefadroxil which could result in a higher serum level.
Cefazolin Injection Cefazolin Injection The risk or severity of nephrotoxicity can be increased when Indomethacin is combined with Cefazolin.
Cephalexin Cephalexin Indomethacin may decrease the excretion rate of Cephalexin which could result in a higher serum level.
Cefoxitin Injection Cefoxitin Injection The risk or severity of nephrotoxicity can be increased when Indomethacin is combined with Cefoxitin.
Dacarbazine Dacarbazine The risk or severity of adverse effects can be increased when Indomethacin is combined with Dacarbazine.
Acetazolamide Acetazolamide The excretion of Indomethacin can be decreased when combined with Acetazolamide.
Cefotaxime Injection Cefotaxime Injection The risk or severity of nephrotoxicity can be increased when Indomethacin is combined with Cefotaxime.
Calcitonin Salmon Injection Calcitonin Salmon Injection Indomethacin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
Bacillus Calmette-Guerin (BCG) Vaccine Bacillus Calmette-Guerin (BCG) Vaccine The risk or severity of infection can be increased when Bacillus calmette-guerin substrain tice live antigen is combined with Indomethacin.
Ketoconazole Ketoconazole The metabolism of Indomethacin can be decreased when combined with Ketoconazole.
Pyrantel Pyrantel Indomethacin may decrease the excretion rate of Pyrantel which could result in a higher serum level.
Thiotepa Injection Thiotepa Injection The risk or severity of adverse effects can be increased when Indomethacin is combined with Thiotepa.
Vincristine Injection Vincristine Injection The risk or severity of adverse effects can be increased when Indomethacin is combined with Vincristine.
Captopril Captopril The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Indomethacin is combined with Captopril.
Dipyridamole Dipyridamole The risk or severity of bleeding and hemorrhage can be increased when Indomethacin is combined with Dipyridamole.
Isoxsuprine Isoxsuprine The risk or severity of hypertension can be increased when Indomethacin is combined with Isoxsuprine.
Vinblastine Vinblastine The risk or severity of adverse effects can be increased when Indomethacin is combined with Vinblastine.
Ethacrynic Acid Ethacrynic Acid The therapeutic efficacy of Indomethacin can be decreased when used in combination with Etacrynic acid.
Colistimethate Injection Colistimethate Injection The risk or severity of nephrotoxicity can be increased when Indomethacin is combined with Colistimethate.
Metoprolol Metoprolol Indomethacin may decrease the antihypertensive activities of Metoprolol.
Aspirin Aspirin The therapeutic efficacy of Acetylsalicylic acid can be decreased when used in combination with Indomethacin.
Salsalate Salsalate The risk or severity of adverse effects can be increased when Indomethacin is combined with Salsalate.
Chlorambucil Chlorambucil The risk or severity of adverse effects can be increased when Chlorambucil is combined with Indomethacin.
Alprazolam Alprazolam Indomethacin may decrease the excretion rate of Alprazolam which could result in a higher serum level.
Temazepam Temazepam Indomethacin may decrease the excretion rate of Temazepam which could result in a higher serum level.
Triazolam Triazolam Indomethacin may decrease the excretion rate of Triazolam which could result in a higher serum level.
Dicyclomine Dicyclomine Indomethacin may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Propantheline Propantheline Indomethacin may decrease the excretion rate of Propantheline which could result in a higher serum level.
Trimethoprim Trimethoprim Indomethacin may decrease the excretion rate of Trimethoprim which could result in a higher serum level.
Diltiazem Diltiazem The therapeutic efficacy of Diltiazem can be decreased when used in combination with Indomethacin.
Nifedipine Nifedipine Nifedipine may decrease the excretion rate of Indomethacin which could result in a higher serum level.
Timolol Timolol Indomethacin may decrease the antihypertensive activities of Timolol.
Verapamil Verapamil The metabolism of Verapamil can be decreased when combined with Indomethacin.
Atenolol Atenolol Indomethacin may decrease the antihypertensive activities of Atenolol.
Pindolol Pindolol Indomethacin may decrease the antihypertensive activities of Pindolol.
Cisplatin Injection Cisplatin Injection The risk or severity of adverse effects can be increased when Indomethacin is combined with Cisplatin.
Diflunisal Diflunisal The therapeutic efficacy of Diflunisal can be decreased when used in combination with Indomethacin.
Piroxicam Piroxicam The risk or severity of adverse effects can be increased when Indomethacin is combined with Piroxicam.
Bumetanide Bumetanide The therapeutic efficacy of Bumetanide can be decreased when used in combination with Indomethacin.
Streptozocin Streptozocin The risk or severity of adverse effects can be increased when Indomethacin is combined with Streptozocin.
Etoposide Etoposide The metabolism of Etoposide can be decreased when combined with Indomethacin.
Glyburide Glyburide Glyburide may decrease the excretion rate of Indomethacin which could result in a higher serum level.
Glipizide Glipizide The protein binding of Glipizide can be decreased when combined with Indomethacin.
Indapamide Indapamide Indomethacin may decrease the excretion rate of Indapamide which could result in a higher serum level.
Amoxicillin Amoxicillin Indomethacin may decrease the excretion rate of Amoxicillin which could result in a higher serum level.
Nafcillin Injection Nafcillin Injection The excretion of Indomethacin can be decreased when combined with Nafcillin.
Oxacillin Injection Oxacillin Injection Indomethacin may decrease the excretion rate of Oxacillin which could result in a higher serum level.
Pentoxifylline Pentoxifylline The risk or severity of bleeding can be increased when Indomethacin is combined with Pentoxifylline.
Pentamidine Injection Pentamidine Injection The risk or severity of nephrotoxicity can be increased when Indomethacin is combined with Pentamidine.
Ceftriaxone Injection Ceftriaxone Injection The excretion of Indomethacin can be decreased when combined with Ceftriaxone.
Labetalol Labetalol Indomethacin may decrease the antihypertensive activities of Labetalol.
Auranofin Auranofin Indomethacin may decrease the excretion rate of Auranofin which could result in a higher serum level.
Leuprolide Injection Leuprolide Injection Indomethacin may decrease the excretion rate of Leuprolide which could result in a higher serum level.
Gemfibrozil Gemfibrozil The metabolism of Indomethacin can be decreased when combined with Gemfibrozil.
Guanabenz Guanabenz The therapeutic efficacy of Guanabenz can be decreased when used in combination with Indomethacin.
Dipivefrin Ophthalmic Dipivefrin Ophthalmic The risk or severity of nephrotoxicity can be increased when Indomethacin is combined with Adefovir dipivoxil.
Ceftazidime Injection Ceftazidime Injection Indomethacin may decrease the excretion rate of Ceftazidime which could result in a higher serum level.
Ketoprofen Ketoprofen The risk or severity of adverse effects can be increased when Indomethacin is combined with Ketoprofen.
Cefotetan Injection Cefotetan Injection Indomethacin may decrease the excretion rate of Cefotetan which could result in a higher serum level.
Enalapril Enalapril The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Indomethacin is combined with Enalapril.
Flurbiprofen Flurbiprofen The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Indomethacin.
Amiodarone Amiodarone The metabolism of Amiodarone can be decreased when combined with Indomethacin.
Aztreonam Injection Aztreonam Injection Indomethacin may decrease the excretion rate of Aztreonam which could result in a higher serum level.
Buspirone Buspirone Indomethacin may decrease the excretion rate of Buspirone which could result in a higher serum level.
Lovastatin Lovastatin The metabolism of Lovastatin can be decreased when combined with Indomethacin.
Ciprofloxacin Ciprofloxacin Indomethacin may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Mesalamine Mesalamine The therapeutic efficacy of Mesalazine can be decreased when used in combination with Indomethacin.
Diclofenac Diclofenac The risk or severity of adverse effects can be increased when Diclofenac is combined with Indomethacin.
Fluoxetine Fluoxetine The risk or severity of gastrointestinal bleeding can be increased when Fluoxetine is combined with Indomethacin.
Nimodipine Nimodipine The therapeutic efficacy of Nimodipine can be decreased when used in combination with Indomethacin.
Interferon Alfa-2b Injection Interferon Alfa-2b Injection The risk or severity of adverse effects can be increased when Interferon alfa-2b is combined with Indomethacin.
Clozapine Clozapine The risk or severity of neutropenia can be increased when Indomethacin is combined with Clozapine.
Estazolam Estazolam Indomethacin may decrease the excretion rate of Estazolam which could result in a higher serum level.
Idarubicin Idarubicin The risk or severity of adverse effects can be increased when Indomethacin is combined with Idarubicin.
Ofloxacin Ofloxacin Indomethacin may decrease the excretion rate of Ofloxacin which could result in a higher serum level.
Didanosine Didanosine Indomethacin may decrease the excretion rate of Didanosine which could result in a higher serum level.
Fludarabine Injection Fludarabine Injection The risk or severity of adverse effects can be increased when Indomethacin is combined with Fludarabine.
Pentostatin Injection Pentostatin Injection The risk or severity of adverse effects can be increased when Indomethacin is combined with Pentostatin.
Clarithromycin Clarithromycin Indomethacin may decrease the excretion rate of Clarithromycin which could result in a higher serum level.
Benazepril Benazepril The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Indomethacin is combined with Benazepril.
Etodolac Etodolac The risk or severity of adverse effects can be increased when Indomethacin is combined with Etodolac.
Felodipine Felodipine The metabolism of Felodipine can be decreased when combined with Indomethacin.
Fosinopril Fosinopril The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Indomethacin is combined with Fosinopril.
Nabumetone Nabumetone The risk or severity of adverse effects can be increased when Indomethacin is combined with Nabumetone.
Pravastatin Pravastatin The excretion of Pravastatin can be decreased when combined with Indomethacin.
Quinapril Quinapril The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Indomethacin is combined with Quinapril.
Ramipril Ramipril The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Indomethacin is combined with Ramipril.
Simvastatin Simvastatin The metabolism of Simvastatin can be decreased when combined with Indomethacin.
Amlodipine Amlodipine Indomethacin may decrease the antihypertensive activities of Amlodipine.
Teniposide Injection Teniposide Injection The risk or severity of adverse effects can be increased when Indomethacin is combined with Teniposide.
Itraconazole Itraconazole The risk or severity of hyperkalemia can be increased when Indomethacin is combined with Itraconazole.
Lisinopril Lisinopril The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Indomethacin is combined with Lisinopril.
Oxaprozin Oxaprozin The risk or severity of adverse effects can be increased when Indomethacin is combined with Oxaprozin.
Atovaquone Atovaquone The metabolism of Indomethacin can be decreased when combined with Atovaquone.
Sotalol Sotalol Indomethacin may decrease the antihypertensive activities of Sotalol.
Bisoprolol Bisoprolol Indomethacin may decrease the antihypertensive activities of Bisoprolol.
Zolpidem Zolpidem The metabolism of Zolpidem can be decreased when combined with Indomethacin.
Doxazosin Doxazosin The metabolism of Doxazosin can be decreased when combined with Indomethacin.
Terazosin Terazosin The therapeutic efficacy of Terazosin can be decreased when used in combination with Indomethacin.
Isradipine Isradipine Isradipine may decrease the excretion rate of Indomethacin which could result in a higher serum level.
Omeprazole Omeprazole The metabolism of Omeprazole can be decreased when combined with Indomethacin.
Cisapride Cisapride The metabolism of Indomethacin can be decreased when combined with Cisapride.
Fluvastatin Fluvastatin The metabolism of Indomethacin can be decreased when combined with Fluvastatin.
Venlafaxine Venlafaxine Venlafaxine may decrease the excretion rate of Indomethacin which could result in a higher serum level.
Stavudine Stavudine The excretion of Stavudine can be decreased when combined with Indomethacin.
Fluvoxamine Fluvoxamine The risk or severity of gastrointestinal bleeding can be increased when Fluvoxamine is combined with Indomethacin.
Nefazodone Nefazodone The risk or severity of gastrointestinal bleeding can be increased when Indomethacin is combined with Nefazodone.
Lamotrigine Lamotrigine The metabolism of Indomethacin can be increased when combined with Lamotrigine.
Losartan Losartan The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Losartan is combined with Indomethacin.
Valacyclovir Valacyclovir Indomethacin may decrease the excretion rate of Valaciclovir which could result in a higher serum level.
Tramadol Tramadol Indomethacin may decrease the excretion rate of Tramadol which could result in a higher serum level.
Vinorelbine Injection Vinorelbine Injection The risk or severity of adverse effects can be increased when Indomethacin is combined with Vinorelbine.
Carboplatin Injection Carboplatin Injection The risk or severity of adverse effects can be increased when Indomethacin is combined with Carboplatin.
Moexipril Moexipril The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Indomethacin is combined with Moexipril.
Lansoprazole Lansoprazole The excretion of Indomethacin can be decreased when combined with Lansoprazole.
Alprostadil Urogenital Alprostadil Urogenital The excretion of Alprostadil can be decreased when combined with Indomethacin.
Ifosfamide Injection Ifosfamide Injection The risk or severity of adverse effects can be increased when Indomethacin is combined with Ifosfamide.
Pegaspargase Injection Pegaspargase Injection The risk or severity of adverse effects can be increased when Pegaspargase is combined with Indomethacin.
Nicardipine Nicardipine The metabolism of Indomethacin can be decreased when combined with Nicardipine.
Bupropion Bupropion Indomethacin may decrease the excretion rate of Bupropion which could result in a higher serum level.
Ticlopidine Ticlopidine The risk or severity of bleeding can be increased when Indomethacin is combined with Ticlopidine.
Saquinavir Saquinavir Indomethacin may decrease the excretion rate of Saquinavir which could result in a higher serum level.
Metformin Metformin Indomethacin may decrease the excretion rate of Metformin which could result in a higher serum level.
Dalteparin Injection Dalteparin Injection The risk or severity of bleeding and hemorrhage can be increased when Indomethacin is combined with Dalteparin.
Nisoldipine Nisoldipine Indomethacin may decrease the excretion rate of Nisoldipine which could result in a higher serum level.
Lamivudine Lamivudine Indomethacin may decrease the excretion rate of Lamivudine which could result in a higher serum level.
Acarbose Acarbose Indomethacin may decrease the excretion rate of Acarbose which could result in a higher serum level.
Glimepiride Glimepiride The protein binding of Glimepiride can be decreased when combined with Indomethacin.
Gemcitabine Injection Gemcitabine Injection The risk or severity of adverse effects can be increased when Indomethacin is combined with Gemcitabine.
Indinavir Indinavir The metabolism of Indomethacin can be decreased when combined with Indinavir.
Ritonavir Ritonavir The metabolism of Indomethacin can be increased when combined with Ritonavir.
Docetaxel Injection Docetaxel Injection The risk or severity of adverse effects can be increased when Indomethacin is combined with Docetaxel.
Cidofovir Injection Cidofovir Injection Indomethacin may decrease the excretion rate of Cidofovir which could result in a higher serum level.
Meropenem Injection Meropenem Injection Indomethacin may decrease the excretion rate of Meropenem which could result in a higher serum level.
Clomipramine Clomipramine The metabolism of Clomipramine can be decreased when combined with Indomethacin.
Zafirlukast Zafirlukast The metabolism of Indomethacin can be decreased when combined with Zafirlukast.
Fosfomycin Fosfomycin Indomethacin may decrease the excretion rate of Fosfomycin which could result in a higher serum level.
Mirtazapine Mirtazapine The risk or severity of hypertension can be increased when Indomethacin is combined with Mirtazapine.
Trandolapril Trandolapril The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Indomethacin is combined with Trandolapril.
Topiramate Topiramate Indomethacin may decrease the excretion rate of Topiramate which could result in a higher serum level.
Zileuton Zileuton The metabolism of Zileuton can be decreased when combined with Indomethacin.
Valsartan Valsartan The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Valsartan is combined with Indomethacin.
Insulin Lispro Injection Insulin Lispro Injection The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Indomethacin.
Pramipexole Pramipexole Indomethacin may decrease the excretion rate of Pramipexole which could result in a higher serum level.
Donepezil Donepezil The metabolism of Donepezil can be decreased when combined with Indomethacin.
Nelfinavir Nelfinavir The metabolism of Indomethacin can be increased when combined with Nelfinavir.
Fexofenadine Fexofenadine The excretion of Fexofenadine can be decreased when combined with Indomethacin.
Loratadine Loratadine Indomethacin may decrease the excretion rate of Loratadine which could result in a higher serum level.
Carvedilol Carvedilol Indomethacin may decrease the antihypertensive activities of Carvedilol.
Nilutamide Nilutamide Indomethacin may decrease the excretion rate of Nilutamide which could result in a higher serum level.
Flutamide Flutamide Indomethacin may decrease the excretion rate of Flutamide which could result in a higher serum level.
Selegiline Selegiline The metabolism of Selegiline can be decreased when combined with Indomethacin.
Bicalutamide Bicalutamide The metabolism of Indomethacin can be decreased when combined with Bicalutamide.
Sertraline Sertraline The risk or severity of bleeding can be increased when Sertraline is combined with Indomethacin.
Propafenone Propafenone Indomethacin may decrease the antihypertensive activities of Propafenone.
Raloxifene Raloxifene The metabolism of Raloxifene can be decreased when combined with Indomethacin.
Irbesartan Irbesartan The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Irbesartan is combined with Indomethacin.
Tamsulosin Tamsulosin Indomethacin may decrease the excretion rate of Tamsulosin which could result in a higher serum level.
Finasteride Finasteride The risk or severity of hypertension can be increased when Indomethacin is combined with Finasteride.
Quetiapine Quetiapine Indomethacin may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Cefepime Injection Cefepime Injection The risk or severity of nephrotoxicity can be increased when Indomethacin is combined with Cefepime.
Cefprozil Cefprozil The risk or severity of nephrotoxicity can be increased when Indomethacin is combined with Cefprozil.
Cefpodoxime Cefpodoxime The risk or severity of nephrotoxicity can be increased when Indomethacin is combined with Cefpodoxime.
Cetirizine Cetirizine Indomethacin may decrease the excretion rate of Cetirizine which could result in a higher serum level.
Paroxetine Paroxetine The risk or severity of gastrointestinal bleeding can be increased when Paroxetine is combined with Indomethacin.
Tolcapone Tolcapone Indomethacin may decrease the excretion rate of Tolcapone which could result in a higher serum level.
Citalopram Citalopram Indomethacin may increase the QTc-prolonging activities of Citalopram.
Capecitabine Capecitabine The metabolism of Indomethacin can be decreased when combined with Capecitabine.
Efavirenz Efavirenz The metabolism of Indomethacin can be increased when combined with Efavirenz.
Abacavir Abacavir Indomethacin may decrease the excretion rate of Abacavir which could result in a higher serum level.
Sildenafil Sildenafil The metabolism of Indomethacin can be decreased when combined with Sildenafil.
Pioglitazone Pioglitazone The risk or severity of hypoglycemia can be increased when Indomethacin is combined with Pioglitazone.
Trastuzumab Injection Trastuzumab Injection Trastuzumab may increase the neutropenic activities of Indomethacin.
Celecoxib Celecoxib The risk or severity of adverse effects can be increased when Indomethacin is combined with Celecoxib.
Rosiglitazone Rosiglitazone Indomethacin may decrease the excretion rate of Rosiglitazone which could result in a higher serum level.
Tolterodine Tolterodine Indomethacin may decrease the excretion rate of Tolterodine which could result in a higher serum level.
Thalidomide Thalidomide The risk or severity of adverse effects can be increased when Indomethacin is combined with Thalidomide.
Oseltamivir Oseltamivir Indomethacin may decrease the excretion rate of Oseltamivir which could result in a higher serum level.
Colesevelam Colesevelam Colesevelam can cause a decrease in the absorption of Indomethacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Balsalazide Balsalazide The therapeutic efficacy of Balsalazide can be decreased when used in combination with Indomethacin.
Nateglinide Nateglinide Indomethacin may decrease the excretion rate of Nateglinide which could result in a higher serum level.
Rabeprazole Rabeprazole Indomethacin may decrease the excretion rate of Rabeprazole which could result in a higher serum level.
Terbinafine Terbinafine The metabolism of Terbinafine can be decreased when combined with Indomethacin.

Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists

Still Confused? Ask the pharmacist a question here!